TTM
−$9.24M
YoY change
—
5Y CAGR
—
Peak year (2019)
$50.04M
Cumulative gross profit
$141.86M
Gross Profit history chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: −$16.56M
Gross Profit growth chart for Revolution Medicines (RVMD) from 2017 to 2025
Latest: -100.0%
Gross Profit history table for Revolution Medicines (RVMD) from 2017 to 2025
| 2025 | −$16.56M | — | −$16.56M | ||
| 2024 | $0.00 | -100.0% | −$11.58M | ||
| 2023 | $11.58M | -67.3% | −$23.80M | ||
| 2022 | $35.38M | +20.4% | +$5.99M | ||
| 2021 | $29.39M | -31.6% | −$13.59M | ||
| 2020 | $42.98M | -14.1% | −$7.06M | ||
| 2019 | $50.04M | +148.2% | +$29.88M | ||
| 2018 | $20.16M | -175.8% | +$46.75M | ||
| 2017 | −$26.59M | — | — |
- 2025−$16.56M—
- 2024$0.00-100.0%
- 2023$11.58M-67.3%
- 2022$35.38M+20.4%
- 2021$29.39M-31.6%
- 2020$42.98M-14.1%
- 2019$50.04M+148.2%
- 2018$20.16M-175.8%
- 2017−$26.59M—
Gross Profit values are taken from Revolution Medicines's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Revolution Medicines (RVMD)
According to Revolution Medicines's latest reported financial statements, the company's current gross profit (TTM) is −$9.24M. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual gross profit for Revolution Medicines (RVMD) came in at −$16.56M.
Revolution Medicines gross profit plunged from $50.04M in 2019 to −$16.56M in 2025, a 133.1% drawdown.
The record annual gross profit stands at $50.04M, reached in 2019; the historical low of −$26.59M was recorded in 2017.
Revolution Medicines Gross Profit by Year
Revolution Medicines Gross Profit 2025: −$16.56M
Revolution Medicines gross profit in 2025 was −$16.56M.
Revolution Medicines Gross Profit 2024: $0.00
2024's gross profit for Revolution Medicines came in at $0.00, plunged 100.0% below 2023.
Revolution Medicines Gross Profit 2023: $11.58M
Revolution Medicines posted gross profit of $11.58M in 2023, plunged 67.3% below 2022.
Revolution Medicines Gross Profit 2022: $35.38M
In 2022, Revolution Medicines reported gross profit of $35.38M, grew 20.4% from 2021.
Revolution Medicines Gross Profit 2021: $29.39M
Revolution Medicines gross profit in 2021 was $29.39M.
See more financial history for Revolution Medicines (RVMD).
Sector peers by Gross Profit
Healthcare peers of Revolution Medicines (RVMD), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Revolution Medicines (RVMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation